Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from p... von Cremolini, C., Loupakis, F., Antoniotti, C., Lonardi, S., Masi, G., Salvatore, L., Cortesi, E., Tomasello, G., Spadi, R., Zaniboni, A., Tonini, G., Barone, C., Vitello, S., Longarini, R., Bonetti, A., D'Amico, M., Di Donato, S., Granetto, C., Boni, L., Falcone, A.

Volltext

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials von Cremolini, C., Loupakis, F., Masi, G., Lonardi, S., Granetto, C., Mancini, M.L., Chiara, S., Moretto, R., Rossini, D., Vitello, S., Allegrini, G., Tonini, G., Bergamo, F., Tomasello, G., Ronzoni, M., Buonadonna, A., Bustreo, S., Barbara, C., Boni, L., Falcone, A.

Volltext

Access of the oncologic patients to the emergency room of the local hospital during the three-year period 2014–2016 von vitello, S., Di Grande, A., Nigro, F., Ciancio, S., Giarratano, G., Raimondi, C., Signorelli, C., Sollami, R., Triglia, E.

Volltext

Treatment in advanced malignant pleural mesothelioma after chemotherapy standard von Vitello, S., Raimondi, C., Sollami, R., Signorelli, C., Triglia, E.

Volltext

Malignant pleural mesothelioma: Scheme therapeutic after standard treatment (study of phase II) von Vitello, S, Giarratano, G, Maiorana, ssa Oriana, Di Cristina

Volltext

Integrated regimen therapeutic (polybiologic-chemotherapy) for melanoma advanced von Vitello, S, Triglia, E, Scuderi, G, Mangione, M

Volltext

Treatment in metastatic prostate cancer with hormone refractory von Vitello, S, Vacirca, F, Triglia, E, Giarratano, G

Volltext

A metronomic treatment with oral chemotherapy in patients elderly with metastatic breast cancer von Vitello, S, Maiorana, O. Dssa, Giarratano, G, Triglia, E, Mangione, M, Cristina, L. Di

Volltext

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with meta... von Cremolini, Chiara, Antoniotti, Carlotta, Rossini, Daniele, Lonardi, Sara, Loupakis, Fotios, Pietrantonio, Filippo, Bordonaro, Roberto, Latiano, Tiziana Pia, Tamburini, Emiliano, Santini, Daniele, Passardi, Alessandro, Marmorino, Federica, Grande, Roberta, Aprile, Giuseppe, Zaniboni, Alberto, Murgioni, Sabina, Granetto, Cristina, Buonadonna, Angela, Moretto, Roberto, Corallo, Salvatore, Cordio, Stefano, Antonuzzo, Lorenzo, Tomasello, Gianluca, Masi, Gianluca, Ronzoni, Monica, Di Donato, Samantha, Carlomagno, Chiara, Clavarezza, Matteo, Ritorto, Giuliana, Mambrini, Andrea, Roselli, Mario, Cupini, Samanta, Mammoliti, Serafina, Fenocchio, Elisabetta, Corgna, Enrichetta, Zagonel, Vittorina, Fontanini, Gabriella, Ugolini, Clara, Boni, Luca, Falcone, Alfredo, Falcone, Alfredo, Lonardi, Sara, De Braud, Filippo Guglielmo Maria, Bordonaro, Roberto, Maiello, Evaristo, Tamburini, Emiliano, Santini, Daniele, Frassineti, Giovanni Luca, Gamucci, Teresa, Aprile, Giuseppe, Zaniboni, Alberto, Granetto, Cristina, Buonadonna, Angela, Di Costanzo, Francesco, Tomasello, Gianluca, Gianni, Luca, Di Donato, Samantha, Carlomagno, Chiara, Clavarezza, Matteo, Racca, Patrizia, Mambrini, Andrea, Roselli, Mario, Allegrini, Giacomo, Sobrero, Alberto, Aglietta, Massimo, Corgna, Enrichetta, Cortesi, Enrico, Corsi, Domenico Cristiano, Ballestrero, Alberto, Bonetti, Andrea, Di Clemente, Francesco, Ruggeri, Enzo, Ciardiello, Fortunato, Benasso, Marco, Vitello, Stefano, Cinieri, Saverio, Mosconi, Stefania, Silvestris, Nicola, Frassoldati, Antonio, Cupini, Samantha, Bertolini, Alessandro, Tortora, Giampaolo, Bengala, Carmelo, Ferrari, Daris, Ardizzoia, Antonia, Milandri, Carlo, Chiara, Silvana, Romano, Gianpiero, Miraglia, Stefania, Scaltriti, Laura, Pucci, Francesca, Blasi, Livio, Brugnatelli, Silvia, Fioretto, Luisa, Ribecco, Angela Stefania, Longarini, Raffaella, Frisinghelli, Michela, Banzi, Maria

Volltext

Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial von Palmeri, S., Leonardi, V., Gebbia, V., De Bella, M.Tamburo, Ferraù, F., Faillú, G., Spatafora, M., Valenza, R., Di Vita, G., Vitello, S., Carroccio, R., Sciortino, G., Vaglica, M., Accurso, V., Agostara, B., Licata, G.

Volltext

Cognitive and Neural Mechanisms Underlying Semantic Ambiguity Resolution von Vitello, S

Volltext bestellen

Outcomes After Endovascular Therapy With Procedural Sedation vs General Anesthesia in Patients With Acute Ischemic Stroke: The AMETIS Randomized Clinical Trial von Chabanne, Russell, Geeraerts, Thomas, Begard, Marc, Balança, Baptiste, Rapido, Francesca, Degos, Vincent, Tavernier, Benoit, Molliex, Serge, Velly, Lionel, Verdonk, Franck, Lukaszewicz, Anne-Claire, Perrigault, Pierre-François, Albucher, Jean-François, Cognard, Christophe, Guyot, Adrien, Fernandez, Charlotte, Masgrau, Aurélie, Moreno, Ricardo, Ferrier, Anna, Jaber, Samir, Bazin, Jean-Etienne, Pereira, Bruno, Futier, Emmanuel

Volltext

518PFOLFOXIRI WITH OR WITHOUT BEVACIZUMAB (BEV) AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): A PROPENSITY SCORE-BASED ANALYSIS von Cremolini, C., Loupakis, F., Rossini, D., Masi, G., Salvatore, L., Barbara, C., Brunetti, I.M., Antoniotti, C., Granetto, C., Cortesi, E., Chiara, S., Vitello, S., Lonardi, S., Ciuffreda, L., Tomasello, G., Ronzoni, M., Buonadonna, A., Tomcikova, D., Boni, L., Falcone, A.

Volltext

Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis von Cremolini, C., Loupakis, F., Rossini, D., Masi, G., Salvatore, L., Barbara, C., Brunetti, I.M., Antoniotti, C., Granetto, C., Cortesi, E., Chiara, S., Vitello, S., Lonardi, S., Ciuffreda, L., Tomasello, G., Ronzoni, M., Buonadonna, A., Tomcikova, D., Boni, L., Falcone, A.

Volltext

DPYD c.1905 + 1G > A and c.2846A > T and UGT1A128 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic co... von Cremolini, C., Del Re, M., Loupakis, F., Marmorino, F., Citi, V., Palombi, M., Bergamo, F., Schirripa, M., Rossini, D., Cortesi, E., Tomasello, G., Spadi, R., Buonadonna, A., Amoroso, D., Vitello, S., Di Donato, S., Granetto, C., D'Amico, M., Falcone, A., Danesi, R.

Volltext

Subgroup Analyses in RAS Mutant, BRAF Mutant and “ALL WT” Metastatic Colorectal Cancer Patients Treated with Folfoxiri Plus Bevacizumab (BEV) or Folfiri Plus BEV in the Tribe Study... von Cremolini, C., Loupakis, F., Lonardi, S., Tomasello, G., Ronzoni, M., Zaniboni, A., Tonini, G., Valsuani, C., Chiara, S., Boni, C., Marcucci, L., Negri, F.V., Barone, C., Vitello, S., D'Amico, M., Granetto, C., Antoniotti, C., Salvatore, L., Fontanini, G., Tomcikova, D., Boni, L., Falcone, A.

Volltext

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone von MARTINELLI, V, COCCO, E, BELLANTONIO, P, AMATO, M. P, GRIMALDI, L. M, TROJANO, M, MANCARDI, G. L, BERGAMASCHI, R, GASPERINI, C, RODEGHER, M, STRAFFI, L, PONZIO, M, CAPRA, R, COMI, G, SALEMI, G, GALLO, P, CAPOBIANCO, M, PESCI, I, GHEZZI, A, POZZILLI, C, LUGARESI, A

Volltext

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from p... von Cremolini, C, Loupakis, F, Antoniotti, C, Lonardi, S, Masi, G, Salvatore, L, Cortesi, E, Tomasello, G, Spadi, R, Zaniboni, A, Tonini, G, Barone, C, Vitello, S, Longarini, R, Bonetti, A, D'Amico, M, Di Donato, S, Granetto, C, Boni, L, Falcone, A

Volltext

The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics von Toh, Sengwee, Rasmussen-Torvik, Laura J, Harmata, Emily E, Pardee, Roy, Saizan, Rosalinde, Malanga, Elisha, Sturtevant, Jessica L, Horgan, Casie E, Anau, Jane, Janning, Cheri D, Wellman, Robert D, Coley, R Yates, Cook, Andrea J, Courcoulas, Anita P, Coleman, Karen J, Williams, Neely A, McTigue, Kathleen M, Arterburn, David, McClay, James

Volltext

The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer... von Falcone, A., Masi, G., Brunetti, I., Benedetti, G., Bertetto, O., Picone, V., Chiara, S., Merlano, M., Vitello, S., Ricci, S.

Volltext